Addus Homecare (NASDAQ:ADUS) had its target price raised by Raymond James from $92.00 to $95.00 in a report released on Wednesday morning, AnalystRatings.com reports. Raymond James currently has an outperform rating on the stock.
Other analysts also recently issued reports about the stock. Zacks Investment Research raised shares of Addus Homecare from a hold rating to a strong-buy rating and set a $94.00 price objective on the stock in a research report on Tuesday, October 8th. Stephens assumed coverage on shares of Addus Homecare in a report on Monday, October 21st. They issued an overweight rating and a $97.00 target price for the company. Oppenheimer set a $91.00 target price on shares of Addus Homecare and gave the company a buy rating in a report on Tuesday, September 17th. BidaskClub lowered shares of Addus Homecare from a strong-buy rating to a buy rating in a report on Tuesday, October 29th. Finally, ValuEngine lowered shares of Addus Homecare from a buy rating to a hold rating in a report on Wednesday, October 2nd. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of Buy and an average price target of $94.00.
Shares of NASDAQ ADUS traded down $1.23 during mid-day trading on Wednesday, reaching $86.57. 150,400 shares of the company’s stock traded hands, compared to its average volume of 131,681. Addus Homecare has a 1-year low of $57.94 and a 1-year high of $92.91. The business has a 50-day simple moving average of $82.95 and a 200 day simple moving average of $77.90. The stock has a market cap of $1.32 billion, a P/E ratio of 51.22, a PEG ratio of 2.76 and a beta of -0.16. The company has a debt-to-equity ratio of 0.15, a current ratio of 5.07 and a quick ratio of 2.84.
In related news, EVP Laurie Manning sold 990 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $83.21, for a total value of $82,377.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 20.10% of the company’s stock.
Several hedge funds have recently bought and sold shares of the stock. Eqis Capital Management Inc. purchased a new position in shares of Addus Homecare in the third quarter valued at $284,000. Mason Street Advisors LLC boosted its stake in shares of Addus Homecare by 31.7% in the 3rd quarter. Mason Street Advisors LLC now owns 4,463 shares of the company’s stock valued at $354,000 after buying an additional 1,075 shares during the period. Tower Research Capital LLC TRC acquired a new stake in shares of Addus Homecare during the 3rd quarter worth about $30,000. SG Americas Securities LLC acquired a new stake in shares of Addus Homecare during the 3rd quarter worth about $962,000. Finally, Security National Trust Co. increased its position in Addus Homecare by 33.8% during the third quarter. Security National Trust Co. now owns 1,500 shares of the company’s stock worth $119,000 after buying an additional 379 shares during the period. 85.54% of the stock is owned by hedge funds and other institutional investors.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.